GE Healthcare Omnipaque 350 contrast injection recalled for particulate matter
GE Healthcare is recalling Omnipaque (iohexol) Injection, 350 mg/mL, over the presence of particulate matter. The action covers 306,810 vials distributed nationwide.
- Product
- OMNIPAQUE — OMNIPAQUE (IOHEXOL)
- Category
- Drug
- Distribution
- Distributed nationwide